Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia 2025

80. Slavin, M. A., & Chakrabarti, A. (2012). Opportunistic Fungal Infections in the Asia-Pacific Region. Medical Mycology, 50(1), 18-25. https://doi.org/10.3109/13693786.2011.602989. 81. Lewnard, J. A., Charani, E., Gleason, A., Hsu, L. Y., Khan, W. A., Karkey, A., Chandler, C. I. R., Mashe, T., Khan, E. A., Bulabula, A. N. H., Donado-Godoy, P ., & Laxminarayan, R. (2024). Burden of bacterial antimicrobial resistance in low- income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis. The Lancet, 403(10442), 2439-2454. https://doi.org/10.1016/s0140-6736(24)00862-6.  82. Tachev, V. (2024). Collaboration Key in Addressing Asia’s Water Scarcity Risk. Climate Impacts Tracker Asia. https://www.climateimpactstracker.com/asia-water-scarcity-risk/. 83. Singh, P . K. (2017). Water, Sanitation and Hygiene: An Essential Ally in a Superbug Age. WHO. https://www.who.int/ southeastasia/news/opinion-editorials/detail/water-sanitation-and-hygiene-an-essential-ally-in-a-superbug-age. 84. Cohen, A., Pillarisetti, A., Luo, Q., Zhang, Q., Li, H., Zhong, G., Zhu, G., Colford, J. M., Smith, K. R., Ray, I., & Tao, Y. (2020). Boiled or Bottled: Regional and Seasonal Exposures to Drinking Water Contamination and Household Air Pollution in Rural China. Environmental Health Perspectives, 128(12), 127002. https://doi.org/10.1289/EHP7124. 85. Zain, A., Sadarangani, S.P ., Shek, L.P .C., Vasoo, S. (2024). Climate change and its impact on infectious diseases in Asia. Singapore Medical Journal, 65:211-9. https://pmc.ncbi.nlm.nih.gov/articles/PMC11132621/pdf/SMJ-65-211.pdf. 86. Malik, H., Singh, R., Kaur, S., Dhaka, P ., Bedi, J. S., Gill, J. P . S., & Gongal, Gyanendra. (2023). Review of Antibiotic Use and Resistance in Food Animal Production in WHO South-East Asia Region. Journal of Infection and Public Health, 16, 172-182. https://doi.org/10.1016/j.jiph.2023.11.002.  87. WHO. (2011). Jaipur Declaration on Antimicrobial Resistance. https://cdn.who.int/media/docs/default-source/searo/india/ antimicrobial-resistance/rev-jaipur-declaration-2014.pdf. 88. Association of Southeast Asian Nations (ASEAN). ASEAN Strategic Framework to Combat Antimicrobial Resistance through One Health Approach [2019-2030]. https://asean.org/wp-content/uploads/2021/10/Agd-6.2.b_ASEAN-Strategic- Framework-to-Combat-AMR_Adopted-by-AHMM.pdf. 89. Chua, A. Q., Verma, M., Hsu, L. Y., & Legido-Quigley, H. (2021). An Analysis of National Action Plans on Antimicrobial Resistance in Southeast Asia Using a Governance Framework Approach. The Lancet Regional Health: Western Pacific, 7, 100084. https://doi.org/10.1016/j.lanwpc.2020.100084. 90. The Fleming Fund. (2023). Capturing data for AMR action in Asia. https://www.flemingfund.org/publications/capturing- data-for-amr-action-in-asia/.  91. ASEAN Secretariat. (2022). Rapid Assessment of the Regulatory Measures in Combating Antimicrobial Resistance (AMR) in the ASEAN Region. https://asean.org/wp-content/uploads/2023/02/Rapid-Assessment-of-the-Regulatory-Measures-in- Combating-Antimicrobial-Resistance-AMR-in-the-ASEAN-Region_-Feb-2023-OK-1.pdf.  92. Mak, K. (2023, 27 February). Speech by Kenneth Mak, Director of Medical Services, Ministry of Health, at the ADVANCE- ID launch symposium, 27 February 2023, [Speech transcript]. Ministry of Health, Singapore. https://www.moh.gov.sg/ newsroom/speech-by-professor-kenneth-mak-director-of-medical-services-ministry-of-health-at-the-advance-id-launch- symposium-27-february-2023. 93. FAIRR Initiative. (2024, 3 September). US $13 Trillion Investors Call on Global Leaders To Tackle Antimicrobial Resistance Crisis [Press release]. https://www.fairr.org/news-events/press-releases/usd13-trillion-investors-call-on-global-leaders-to- tackle-antimicrobial. 94. L.E.K. (2021). Asia-Pacific in the Eye of AMR Storm: Nurturing Innovation To Fight Antimicrobial Resistance. https://www.lek.com/sites/default/files/PDFs/Nurturing-Innovation-AMR-management.pdf . 95. Baker McKenzie. (2024, 5 April). Healthcare and Life Sciences in Asia Pacific: 2024 sets to see rising investment and innovation [Press release]. https://www.bakermckenzie.com/en/newsroom/2024/04/healthcare-and-life-sciences-in- ap-2024; HSBC. (2024). Fit for the Future: A Bright Outlook for Business Growth in ASEAN Healthcare. https://www. business.hsbc.com.sg/en-sg/insights/growing-my-business/fit-for-the-future-a-bright-outlook-for-business-growth-in- asean-healthcare. 96. United Nations Development Programme (UNDP). (2024). Private Finance for the SDGs: SDG Investor Platform. https://sdgprivatefinance.undp.org/leveraging-capital/sdg-investor-platform. 97. Derep, M. (2022). What’s the average time to bring a drug to market in 2022? N-Side. https://lifesciences.n-side.com/blog/ what-is-the-average-time-to-bring-a-drug-to-market-in-2022.   98. Dellit, T.H., Owens, R.C., McGowan, J.E., Gerding, D.N., Weinstein, R.A., Burke, J.P ., Huskins, W.C., Paterson, D.L., Fishman, N.O., Carpenter, C.F., Brennan, P .J., Billeter, M., & Hooton, T.M. (2007). Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship. Clinical Infectious Diseases, 44(2), 159-177. https://doi.org/10.1086/510393. 99. WHO. Promoting antimicrobial stewardship to tackle antimicrobial resistance. (2025). https://www.who.int/europe/ activities/promoting-antimicrobial-stewardship-to-tackle-antimicrobial-resistance.  100. Chang, F.-Y., Chuang, Y.C., Veeraraghavan, B., Apisarnthanarak, A., Tayzon, M.F., Kwa, A.L., Chiu, C.-H., Deris, Z.Z., Amir Husin, S., Hashim, H., Karuniawati, A., Ahmed, A., Matsumoto, T., Nguyen, V. K., & Dinh, T.T.H. (2022). Gaps in Antimicrobial Stewardship Programmes in Asia: A Survey of 10 Countries. JAC-Antimicrobial Resistance, 4(6), dlac117. https://doi.org/10.1093/jacamr/dlac117.  Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia 47